VC fund profile · evidence-aware directory data
Juvia Group stages, portfolio and investment profile
Juvia Group is a biotechnology investment firm founded in 2026 by healthcare investors, operators and entrepreneurs. It led Soufflé Therapeutics' October 2026 $135M Series B.
Keep track of Juvia Group
Save this profile to your VCT watchlist for a quick return.
Stage-based planning range
$100K–$1M
This is a planning range inferred from stage coverage, not a firm-disclosed check size.
Methodology: Stage bucket inferred from the rounds a fund leads or invests in.
No firm-specific check-size disclosure is recorded.
Investment stages
Leads: Series B
Participates: Series B
Sector focus
biotech-life-sciences · healthtech
Geography
Not recorded
Founded 2026
Fund size / AUM
Not recorded
A separate fund-size evidence record is not yet available.
Portfolio in our directory
1
Linked startup profiles
Latest fund vehicle
Not recorded
Vehicle name, size, and vintage are not yet structured.
Recent tracked investment
Not recorded
No dated round explicitly links this fund.
Rounds they lead
Rounds they invest
Last verified: 2026-10-15. Check-size evidence is labeled by basis so planning estimates are not presented as firm disclosures.
Portfolio companies we track
Startups in our directory that list Juvia Group as an investor (1 total).
Related investment articles
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.